Loading company…
Vor Biopharma, based in Massachusetts, develops cell therapies for hematological malignancies.
Based in Massachusetts, US, Vor Biopharma, Inc. is a biotechnology company founded by Robert Ang that develops cell therapy for patients with hematological malignancies. It has raised a total of USD 152 million in two funding rounds from investors including 5AM Ventures, Johnson & Johnson Innovation, PureTech Health and RA Capital. In March 2026, TCG Crossover Management agreed to acquire the company for USD 75 million, or USD 14.05 per share, in a PIPE transaction.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in